News  ›  Article

Farris LLP: Vancouver's Law Firm


23 July 2009

James Hatton Appears in Lexpert Magazine’s Big Deals Section

On April 8, 2009, Cardiome Pharma Corp. of Vancouver signed a licensing deal with Merck & Co., Inc., worth up to $1 billion if all milestones are met, which would make it the largest Canadian lifesciences licensing deal in history. Merck will pay US$60 million up front and provide a $100 million line of credit with an additional $300 million in clinical milestone payments and $340 million in commercial milestones, along with tiered royalties for the commercialization of the drug vernakalant, which is being investigated as a treatment for atrial fibrillation, an abnormal heart rhythm.

Farris Partner James Hatton and Barbara Kosacz of Cooley Godward Kronish acted for Cardiome, and Anke Kramer, in-house counsel, represented Merck.

‹ Back